FDA.reportPublic FDA data

SODIUM CARBONATE

Substance profile for UNII 45P3261C7T, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SODIUM CARBONATE
Structure render from PubChem CID 10340

Substance Identity#

UNII
45P3261C7T
Preferred term
SODIUM CARBONATE
Registry number
497-19-8
EC number
207-838-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
CO3.2Na
Chemical structure for SODIUM CARBONATE
Structure render from PubChem CID 10340

Chemical And Database Identifiers#

InChIKey
CDBYLPFSWZWCQE-UHFFFAOYSA-L
SMILES
[Na+].[Na+].[O-]C([O-])=O
RxCUI
36685
PubChem
10340
NCIt
C47721
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound10340https://pubchem.ncbi.nlm.nih.gov/compound/10340
PubChem InChIKey SearchCDBYLPFSWZWCQE-UHFFFAOYSA-Lhttps://pubchem.ncbi.nlm.nih.gov/#query=CDBYLPFSWZWCQE-UHFFFAOYSA-L
RxNorm36685https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=36685
NCI ThesaurusC47721https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47721
FDA Substance Registration System45P3261C7Thttps://precision.fda.gov/uniisearch/srs/unii/45P3261C7T
European Community number207-838-8https://commonchemistry.cas.org/results?q=207-838-8

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use ATORVASTATIN calcium tablets safely and effectively. See full prescribing information for ATORVASTATIN calcium tablets. ATORVASTATIN calcium tablets for oral administration Initial U.S. Approval: 19961
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM2
Sodium CarbonateINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM5
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TGoutFlex Gout Symptom Formula1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMetformin Hydrochloride Extended-release Tablets, USP4
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use PANTOPRAZOLE sodium delayed-release tablets, USP safely and effectively. See full prescribing information for PANTOPRAZOLE sodium delayed-release tablets, USP. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral administration Initial U.S. approval: 200011
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TGout Symptom Relief™1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets USP, for oral administration Initial U.S. approval: 20002
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE Sodium delayed-release tablets USP for oral use Initial U.S. approval: 20001
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets USP safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets USP. PANTOPRAZOLE Sodium Delayed-Release Tablets USP for oral use Initial U.S. Approval: 20002
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19962
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20001
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TGout Symptom Reliever1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMcKesson Nicotine Polacrilex Gum USP, 2 mg (nicotine) Drug Facts2
Sodium carbonateINACTIVE INGREDIENT45P3261C7TBayer ® Advanced Aspirin 325 mg Coated Tablet2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets. PANTOPRAZOLE SODIUM delayed-release tablets Initial U.S. approval: 20003
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7T9b73e20a-4ac8-4111-a69e-17ee1bca8e651
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral use Initial U.S. Approval: 20001
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use ATORVASTATIN CALCIUM safely and effectively. See full prescribing information for ATORVASTATIN CALCIUM. ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) TABLET, FILM COATED for ORAL use. Initial U.S. Approval: 20123
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use PANTOPRAZOLE SODIUM safely and effectively. See full prescribing information for PANTOPRAZOLE SODIUM. PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM) TABLET for ORAL use. Initial U.S. Approval: 20073
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TOverly-Sensitive™1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19964
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TClimate Adaptation Hot and Dry™1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pravastatin sodium safely and effectively. See full prescribing information for pravastatin sodium tablets. Initial U.S. Approval: 19911
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TMorale Remedy No. 191
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAllergyEase Food and Chemical1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19963
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19961
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TCyclopentolate Hydrochloride Ophthalmic Solution USP, 1% (Sterile)2
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAllergy Food and Chemical Relief1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAgoraFear Relief1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7THomeopathic Tension Headache Formula1
Sodium CarbonateACTIVE INGREDIENT45P3261C7TCalm Remedy Water ®3
Sodium CarbonateACTIVE INGREDIENT45P3261C7TControl Remedy Water ®3
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TDrug Facts1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAcid Detox3
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAttention and Learning Enhancement3
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TGood Mood Enhancer1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20002
Sodium CarbonateINACTIVE INGREDIENT45P3261C7T8a023942-01e8-4849-aa3c-1a640ffc7fd37
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use PROTONIX safely and effectively. See full prescribing information for PROTONIX. PROTONIX (pantoprazole sodium) delayed-release tablets PROTONIX (pantoprazole sodium) for delayed-release oral suspension Initial U.S. approval: 20001
Sodium CarbonateACTIVE INGREDIENT45P3261C7TConnective Tissue5
Sodium CarbonateACTIVE INGREDIENT45P3261C7TEdema3
Sodium CarbonateACTIVE INGREDIENT45P3261C7TWarts - Moles - Skin Tags3
Sodium CarbonateACTIVE INGREDIENT45P3261C7TCandidiasis~Yeast2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TLymphatic Drainer2
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TCold Sore Complex1
Sodium CarbonateACTIVE INGREDIENT45P3261C7TConnective Tissue1
Sodium CarbonateACTIVE INGREDIENT45P3261C7TEdema1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMetformin Hydrochloride Extended - Release Tablets2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TIndigestion - Gas2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TIndigestion - Gas2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TThroat Care2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TThroat Care2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TWarts - Moles - Skin Tags2
Sodium CarbonateACTIVE INGREDIENT45P3261C7TTummy Upset1
Sodium CarbonateACTIVE INGREDIENT45P3261C7TWarts - Moles - Skin Tags1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets, USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets, USP. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20002
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20001
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use PROTONIX safely and effectively. See full prescribing information for PROTONIX. PROTONIX (pantoprazole sodium) delayed-release tablets PROTONIX (pantoprazole sodium) for delayed-release oral suspension Initial U.S. approval: 20001
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets. PANTOPRAZOLE SODIUM delayed-release tablets Initial U.S. approval: 20001
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TAllergy Composition3
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMetformin Hydrochloride Extended - Release Tablets1
Sodium CarbonateINACTIVE INGREDIENT45P3261C7TPantoprazole Sodium Delayed-Release Tablets1
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7T8459857e-1a52-45de-81e6-e06ce18508bb2
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3263
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1001
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPRAVASTATIN SODIUM TABLET [BRYANT RANCH PREPACK]1000
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) GRANULE, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]26
Sodium CarbonateINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [JUBILANT CADISTA PHARMACEUTICALS INC.]18
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMEROPENEM INJECTION, POWDER, FOR SOLUTION [SANDOZ INC]17
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]15
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TMERREM IV (MEROPENEM) INJECTION [ASTRAZENECA PHARMACEUTICALS LP]14
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]14
sodium carbonateINACTIVE INGREDIENT45P3261C7TFUZEON (ENFUVIRTIDE) KIT [GENENTECH, INC.]13
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TNICORETTE WHITE ICE MINT (NICOTINE POLACRILEX) GUM, CHEWING NICORETTE ORIGINAL (NICOTINE POLACRILEX) GUM, CHEWING NICORETTE CINNAMON SURGE (NICOTINE POLACRILEX) GUM, CHEWING NICORETTE FRESH MINT (NICOTINE POLACRILEX) GUM, CHEWING NICORETTE MINT (NICOTINE POLACRILEX) GUM, CHEWING NICORETTE SPEARMINT BURST (NICOTINE POLACRILEX) GUM, CHEWING [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]13
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TTAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]13
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]12
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.]12
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]12
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TCEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SANDOZ INC]12
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TCEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SANDOZ INC]12
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [APOTEX CORP.]11
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.]11
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]11
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]11
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE TABLET, DELAYED RELEASE [DR.REDDY'S LABORATORIES LIMITED]11
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TFENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.]10
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TNICORETTE (NICOTINE POLACRILEX) LOZENGE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]10
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TNICORETTE FRUIT CHILL (NICOTINE POLACRILEX) GUM, CHEWING [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]10
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [TORRENT PHARMACEUTICALS LIMITED]10
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TCYCLOPENTOLATE HYDROCHLORIDE SOLUTION/ DROPS [BAUSCH & LOMB INCORPORATED]9
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TNICORETTE (NICOTINE POLACRILEX) LOZENGE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]9
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS]9
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [MAJOR PHARMACEUTICALS]8
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TNICOTINE POLACRILEX GUM, CHEWING [TARGET CORPORATION]8
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [ACTAVIS INC.]8
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) GRANULE, DELAYED RELEASE [CARDINAL HEALTH]8
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TATORVASTATIN CALCIUM TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.]7
Sodium carbonateINACTIVE INGREDIENT45P3261C7TBINOSTO (ALENDRONATE SODIUM) TABLET, EFFERVESCENT [MISSION PHARMACAL COMPANY]7
sodium carbonateINACTIVE INGREDIENT45P3261C7TINTERMEZZO (ZOLPIDEM TARTRATE) TABLET [PURDUE PHARMA LP]7
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TNICOTINE ORIGINAL (NICOTINE POLACRILEX) LOZENGE NICOTINE (NICOTINE POLACRILEX) LOZENGE [WALGREENS]7
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.]7
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TPRAVASTATIN SODIUM TABLET [ZYDUS PHARMACEUTICALS (USA) INC.]7
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TRUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR (NICOTINE POLACRILEX) GUM, CHEWING [RUGBY LABORATORIES]7
SODIUM CARBONATEINACTIVE INGREDIENT45P3261C7TBREVITAL SODIUM (METHOHEXITAL SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PAR PHARMACEUTICAL, INC.]6
sodium carbonateINACTIVE INGREDIENT45P3261C7TCEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]6
SODIUM CARBONATEACTIVE INGREDIENT45P3261C7TGOUTINEX GOUT SYMPTOM RELIEF (ACTAEA SPICATA, AMMONIUM PHOSPHORICUM, BELLADONNA, COLCHICUM AUTUMNALE, FORMICUM ACIDUM, FRAXINUS EXCELSIOR, LEDUM PALUSTRE, NATRUM CARBONICUM, NUX VOMICA, PHYTOLACCA DECANDRA, RHODODENDRON CHRYSANTHUM, SALICYLICUM ACIDUM, URTICA URENS) LIQUID [IONX HOLDINGS D/B/A HELLOLIFE INC.]6